Charles W. Newton
Director · 6 filings · Latest: Aug 18, 2026
Coherus Oncology, Inc.
Keros Therapeutics, Inc.
NOVAVAX INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KROS | Charles W. Newton | Director | Aug 18, 2026 | Sale | $10.30 | 551 | $5.7K | 12,114 | |
KROS | Newton Charles W. | — | Aug 18, 2026 | Proposed Sale | $10.38 | 551 | $5.7K | — | |
KROS | Charles W. Newton | Director | Jun 11, 2026 | Sale | $10.04 | 550 | $5.5K | 12,665 | |
KROS | Newton Charles W. | — | Jun 11, 2026 | Proposed Sale | $9.95 | 550 | $5.5K | — | |
NVAX | Charles W. Newton | Director | Apr 25, 2026 | Option Exercise | $0.00 | 9,520 | — | 9,520 |